Association between routine anticoagulation and pregnancy outcomes in women with heterozygous Factor V Leiden genotype.

Abstract excerpt

BACKGROUND: Inherited thrombophilia, particularly heterozygous Factor V Leiden (G1691A) mutation, has been linked to placental vascular complications and adverse pregnancy outcomes. However, the benefit of antenatal anticoagulation in affected women without prior venous thromboembolism remains uncertain. AIM: To assess the association between antenatal anticoagulant therapy and pregnancy outcomes in women...

Topics

• Humans
• Female
• Pregnancy
• Factor V
• Anticoagulants
• Thrombophilia
• Pregnancy Outcome